Renowned Indian-American radiation oncologist Dr. Nori Dattatreyudu has been conferred the Padma Bhushan for his extraordinary contributions to the field of medicine. The Ministry of Home Affairs included him in the 2026 Padma Awards list announced on Republic Day. The award recognises his decades-long efforts in advancing cancer treatment and improving patient outcomes worldwide.
Dr. Nori is celebrated for his pioneering work in high-dose-rate brachytherapy, a technique that allows highly targeted radiation to cancerous tissues while minimising harm to healthy cells. His innovations in remote after-loading brachytherapy have transformed treatment for cancers of the cervix, urinary system, chest, head, and neck. Since its introduction in the 1970s, his methods have become a global standard, benefiting millions of patients.
Over his distinguished career, Dr. Nori has led numerous clinical trials under the US National Cancer Institute and earned recognition as a leading figure in radiation oncology. Among his accolades are the Ellis Island Medal of Honour in 2014 and the Padma Shri in 2015. He has consistently been ranked among the top oncologists in the United States, particularly for his work in women’s cancers.
Born in Mantada village of Krishna district, Andhra Pradesh, Dr. Nori completed his medical studies at Kurnool Medical College and pursued postgraduate education at Osmania Medical College. His contributions exemplify the impact of Indian talent on global healthcare and underscore the importance of innovation in cancer treatment.
The Padma Bhushan is one of India’s highest civilian awards, granted for distinguished service of high order, and will be formally presented by President Droupadi Murmu in a ceremony at Rashtrapati Bhavan, typically held in March or April.
